13 new papers
this month, from drug development to naloxone programming, epidemiology to practice
management, toxicology to supply side drug control.
Li W, Gunja
N.
Aust Fam
Physician. 2013 Jul;42(7):481-5.
Comment: Unable to access. Appears to be a general review of managing
illicit drug toxicities.
Leece PN,
Hopkins S, Marshall C, Orkin A, Gassanov MA, Shahin RM.
Can J
Public Health. 2013 Apr 18;104(3):e200-4.
Comment: Unable to access. There have been
several papers describing the initial experience of naloxone programs and this
is a welcome addition to that literature.
Centers for
Disease Control and Prevention (CDC).
MMWR Morb
Mortal Wkly Rep. 2013 Jul 5;62(26):537-42.
Comment: A review of drug overdose mortality
data among women, demonstrating that women have been particularly affected by
the recent epidemic.
Coffin PO,
Sullivan SD.
J Med Econ.
2013 Jun 19. [Epub ahead of print]
Comments: An adaptation of the model
developed for the United States, taking into account structural differences, epidemiologic
data, and costs in Russia. Because of limitations in emergency medical services
in Russia, the high rate at which overdoses are witnessed, and the very low
costs of naloxone, this intervention is likely to be even more cost-effective
in Russia than it appears to be in the United States.